University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 10 of 18
Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.
NCT03428490
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
NCT02866682
Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse
NCT03175159
The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects
NCT03713164
Gender Identity and Own Body Perception
NCT04374708
Affective Management Training for Cannabis Misuse
NCT03432013
Transcranial Direct Current Stimulation in Major Depression
NCT03556124
Positive Steps to Enhance Problem Solving Skills
NCT03092531
The Effect of a Healthy Snack on Body Weight and Composition
NCT03159689
Investigating Circadian Rhythms in Youth With Persistent Tic Disorders
NCT03508245
Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
NCT03059563
Target Engagement and Response to Oxytocin
NCT03245437
A Comparative Study of Electric Toothbrushes for the Efficacy Plaque Removal and the Effect on Plaque Accumulation and Gingivitis.
NCT03416985
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
NCT03294109
Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses
NCT04686552
Mobile Coach for Parents of Children and Adolescents With Chronic Pain
NCT03356275
NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial
NCT04167085
Virtual Reality Experience in First Trimester D&C
NCT03533036
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year
NCT03361410
HPV Centralized R/R RCT #2 - New York State
NCT03294551
Centralized Reminder Recall - Flu RCT2
NCT03294473
Transfusion Using Stored Whole Blood
NCT02926274
Financial Incentives for Weight Reduction Study
NCT03157713
Adolescent Acts of Kindness Intervention
NCT03322397
StriveWeekly: Self-Guided Online Intervention for Anxiety, Depression, and Stress in University Students
NCT04361045
Attention Training for Underserved Youth With Anxiety
NCT03028792
Effect of Spice Consumption on the Microbiome
NCT03676803
Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice
NCT03924531
Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection
NCT03205696
Study of Pomaglumetad and Methamphetamine
NCT03106571
Impact of Mindful Awareness Practices in Pediatric Residency Training
NCT03613441
Utilizing Traditional Practices
NCT03164577
Liver Fat and Iron Quantification MRI
NCT03162302
Mobile Self Management and Support for Adolescents and Young Adults With Cancer
NCT03130751
Improving Older Adults' Decision Making for OSAT
NCT03138993
Stress-Induced Inflammation and Reward Processing
NCT03828604
Engaging Seronegative Youth to Optimize HIV Prevention Continuum
NCT03134833
Stepped Care for Youth Living With HIV
NCT03109431
Preoperative Alpha Blockade for Pheochromocytoma
NCT03176693
Initial Development and Dissemination of OC-Go
NCT03126305
Aging Mastery Program® (AMP) Evaluation
NCT03342729
Randomized Trial of a Social Networks Intervention
NCT03059433
Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults
NCT03092271
Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia
NCT03349892
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
NCT03022292
FODMAP Reintroduction in Irritable Bowel Syndrome
NCT03245645
CONNECT for Depressed Cannabis Users Trial
NCT03727659
Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes
NCT03092063
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
NCT03051204
HPV IIS Reminder/Recall- New York State
NCT03057379
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.